156 related articles for article (PubMed ID: 38379666)
41. Curative Surgery Improves Survival for Colorectal Cancer in Rural Kenya.
Parker RK; Mwachiro MM; Ranketi SS; Mogambi FC; Topazian HM; White RE
World J Surg; 2020 Jan; 44(1):30-36. PubMed ID: 31650225
[TBL] [Abstract][Full Text] [Related]
42. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
[TBL] [Abstract][Full Text] [Related]
43. Assessing Factors Associated With Survival Among Cervical Cancer Patients in Kenya: A Retrospective Follow-up Study.
Osok D; Karanja S; Kombe Y; Njuguna E; Todd J
East Afr Health Res J; 2018; 2(2):118-127. PubMed ID: 34308182
[TBL] [Abstract][Full Text] [Related]
44. Surgical candidacy and treatment initiation among women with cervical cancer at public referral hospitals in Kampala, Uganda: a descriptive cohort study.
Swanson M; Nakalembe M; Chen LM; Ueda S; Namugga J; Nakisige C; Huchko MJ
BMJ Open; 2020 Dec; 10(12):e039946. PubMed ID: 33310800
[TBL] [Abstract][Full Text] [Related]
45. Association between stage at diagnosis and knowledge on cervical cancer among patients in a Kenyan tertiary hospital: a cross-sectional study.
Wamburu K; Busakhala N; Owuor K; Nyagero J
Pan Afr Med J; 2016; 25(Suppl 2):15. PubMed ID: 28439339
[TBL] [Abstract][Full Text] [Related]
46. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of PD-1 inhibitor combined with concurrent chemoradiotherapy in locally advanced cervical cancer with pelvic and/or para-aortic lymph node metastases: a retrospective cohort study.
Liu C; Ran X; Wang Z; Zhang K
Chin Clin Oncol; 2023 Aug; 12(4):38. PubMed ID: 37699603
[TBL] [Abstract][Full Text] [Related]
48. Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia.
Anfinan N; Sait K
Ann Saudi Med; 2020; 40(1):25-35. PubMed ID: 32026705
[TBL] [Abstract][Full Text] [Related]
49. Cervical cancer survival in a resource-limited setting-North Central Nigeria.
Musa J; Nankat J; Achenbach CJ; Shambe IH; Taiwo BO; Mandong B; Daru PH; Murphy RL; Sagay AS
Infect Agent Cancer; 2016; 11():15. PubMed ID: 27014366
[TBL] [Abstract][Full Text] [Related]
50. Factors associated with late diagnosis of cervical cancer at two national referral hospitals, Kenya 2017: A case control study.
Mwenda V; Mwangi M; Gathecha G; Kibachio J; Too R; Gura Z; Temmerman M
Gynecol Oncol Rep; 2024 Apr; 52():101355. PubMed ID: 38500641
[TBL] [Abstract][Full Text] [Related]
51. Determinants of Cervical Cancer Screening Among Women Aged 30-49 Years Old in Four African Countries: A Cross-Sectional Secondary Data Analysis.
Alie MS; Negesse Y; Ayenew M
Cancer Control; 2023; 30():10732748231195681. PubMed ID: 37656980
[TBL] [Abstract][Full Text] [Related]
52. Cervical cancer in southern Malawi: A prospective analysis of presentation, management, and outcomes.
Rudd P; Gorman D; Meja S; Mtonga P; Jere Y; Chidothe I; Msusa AT; Bates MJ; Brown E; Masamba L
Malawi Med J; 2017 Jun; 29(2):124-129. PubMed ID: 28955419
[TBL] [Abstract][Full Text] [Related]
53. Self-reported use of internet by cervical cancer clients in two National Referral Hospitals in Kenya.
Kivuti-Bitok LW; McDonnell G; Pokhariyal GP; Roudsari AV
BMC Res Notes; 2012 Oct; 5():559. PubMed ID: 23046538
[TBL] [Abstract][Full Text] [Related]
54. Use of a Novel Trigger Tool to Identify Palliative Care Needs in Surgical Patients at a National Referral Hospital in Kenya: A Pilot Study.
Li HW; Saruni SI; Carpenter K; Chepkemoi E; Ochieng NA; Obanda LN; Haskett L; Cornetta K; Brown C; Korir M; Keung CH; Kussin PS
J Palliat Med; 2021 Sep; 24(10):1455-1460. PubMed ID: 33625266
[No Abstract] [Full Text] [Related]
55. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY
J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
[TBL] [Abstract][Full Text] [Related]
56. [Analysis of clinical efficiency of treatment for 179 geriatric women with stage I or II cervical carcinoma].
Huang YW; Li MD; Liu FY; Li YF
Ai Zheng; 2002 Nov; 21(11):1238-40. PubMed ID: 12526224
[TBL] [Abstract][Full Text] [Related]
57. Profile of treatment-related complications in women with clinical stage IB-IIB cervical cancer: A nationwide cohort study in Japan.
Machida H; Matsuo K; Furusawa A; Kita T; Kitagawa R; Mikami M
PLoS One; 2019; 14(1):e0210125. PubMed ID: 30615679
[TBL] [Abstract][Full Text] [Related]
58. Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer.
Nama V; Angelopoulos G; Twigg J; Murdoch JB; Bailey J; Lawrie TA
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011478. PubMed ID: 30311942
[TBL] [Abstract][Full Text] [Related]
59. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
